Related Experiment Videos
Modified allergen immunotherapy: effect on immunoglobulin E production
A A Babakhin1, R M Khaitov, R V Petrov
1Russian Federal Institute of Immunology and Academy of Sciences of Russia, Moscow.
Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|July 1, 1995
Summary
New allergen immunotherapy uses modified allergens to safely induce T-cell responses. This approach avoids increased immunoglobulin E (IgE) responses, offering a novel desensitization strategy.
Area of Science:
- Immunology
- Allergen immunotherapy
- Synthetic polymer chemistry
Background:
- Allergen immunotherapy aims to desensitize patients to allergens.
- Current methods can sometimes trigger unwanted immunoglobulin E (IgE) responses.
- Need for safer and more effective immunotherapy strategies.
Purpose of the Study:
- To explore novel allergen immunotherapy approaches.
- To investigate modified allergens that modulate T-cell responses.
- To assess the impact on IgE-related responses and immunoglobulin production.
Main Methods:
- Utilizing modified allergens for immunotherapy.
- Employing synthetic polyelectrolytes as carrier molecules.
- Analyzing T-cell and B-cell function modulation.
- Evaluating changes in immunoglobulin production.
Main Results:
- Modified allergens induce T-cell responses.
- No associated increase in IgE-related responses was observed.
- Synthetic polyelectrolytes modulated T- and B-cell function.
- Desensitization was achieved, with immunoglobulin production altered by carrier molecule properties.
Conclusions:
- Modified allergens offer a promising new avenue for allergen immunotherapy.
- This approach can achieve T-cell mediated desensitization without exacerbating IgE responses.
- Synthetic polyelectrolyte carriers can be tailored to optimize immunotherapy outcomes.